In a landmark analysis, Ference et al. [26] demonstrated that lifelong lower Apo B levels, determined by genetic variants, are associated with proportionally greater reductions in coronary artery disease risk compared to equivalent reductions in LDL-C or non-HDL-C. The gene discussed is APOB; the disease is coronary artery disorder.